SCT510
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SCT510, covering 2019-01-03 to 2024-02-01. Get the full timeline:
Most recent: Clinical Trial Update: SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma [Phase 2, Phase 3]